AR and Familial prostate cancer: Having validated the capture definition, the informative cell population may now be interrogated for additional biomarkers of value such as expression of protein markers [38], protein modification events, or RNA expression based analysis for biomarkers that are opaque in the DNA compartment such as the AR-V7 splice variant in prostate cancer [39].